Titre:
  • 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia.
Auteur:Van Den Neste, Eric; Martiat, Philippe; Mineur, Philippe; Delannoy, André; Doyen, C; Zenebergh, A; Michaux, Jean Louis; Ferrant, Augustin
Informations sur la publication:Annals of hematology, 76, 1, page (19-23)
Statut de publication:Publié, 1998-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Adult
Aged
Antineoplastic Agents -- therapeutic use
Cladribine -- administration & dosage
Cladribine -- adverse effects
Cladribine -- therapeutic use
Daunorubicin -- administration & dosage
Daunorubicin -- adverse effects
Female
Humans
Leukemia, Myeloid, Acute -- drug therapy
Leukemia, Myeloid, Acute -- mortality
Male
Middle Aged
Recurrence
Survival Rate
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Langue:Anglais
Identificateurs:urn:issn:0939-5555
info:pmid/9486920